title: Human keratinocyte migration on type IV collagen. Roles of heparin-binding site and alpha 2 beta 1 integrin.
abstract: BACKGROUND
  The migration of human keratinocytes is an early and important event in the re-epithelialization of cutaneous wounds. Type IV collagen, a ubiquitous basement membrane component, promotes keratinocyte migration.
  
  
  METHODS
  In this study, we sought to identify specific sites within the type IV collagen molecule that induce keratinocyte locomotion and to characterize the cell surface receptors involved. We first examined purified fragments of the type IV collagen molecule as substrates for keratinocytes in a phagokinetic migration assay. We then tested several synthetic peptides derived from the triple-helical region of type IV collagen, as well as antibodies against specific integrin subunits, for their ability to either support or inhibit keratinocyte migration on matrices of both type IV collagen and relevant peptide derivatives.
  
  
  RESULTS
  Keratinocytes migrated on the triple-helical fragment to the same extent as they did on the native type IV collagen. The amino-terminal 7S and the carboxy-terminal NC1 regions of type IV collagen failed to support keratinocyte migration. In addition, Hep III peptide was active both in inhibiting keratinocyte migration on type IV collagen and in serving as a substrate matrix for migration. Peptide containing the amino acid sequence RGD did not influence cell migration on type IV collagen. A specific monoclonal antibody against the alpha 2 beta 1 integrin receptor significantly inhibited keratinocyte migration on matrices of both type IV collagen and Hep III peptide.
  
  
  CONCLUSIONS
  Keratinocyte migration on type IV collagen involves the interaction of the alpha 2 beta 1 receptor with the Hep III region of the type IV collagen molecule.
authors.affiliation: Department of Dermatology, Stanford University School of Medicine, California.
authors.forename: J P
authors.initials: JP
authors.lastname: Kim
authors.forename: J D
authors.initials: JD
authors.lastname: Chen
authors.forename: M S
authors.initials: MS
authors.lastname: Wilke
authors.forename: T J
authors.initials: TJ
authors.lastname: Schall
authors.forename: D T
authors.initials: DT
authors.lastname: Woodley
mesh_terms: D001665:Binding Sites / Q000502:physiology; D002465:Cell Movement / Q000187:drug effects; D003094:Collagen / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D024141:Collagen Type IV; D006493:Heparin / Q000378:metabolism*; D006801:Humans; D016023:Integrins / Q000502:physiology*; D015603:Keratinocytes / Q000502:physiology*; D010446:Peptide Fragments / Q000378:metabolism / Q000494:pharmacology
chemical_list: D024141:Collagen Type IV; D016023:Integrins; D010446:Peptide Fragments; C065384:collagen type IV alpha1 (531-543); D006493:Heparin; D003094:Collagen